Cost-effectiveness of insulin degludec versus insulin glargine U100 in adults with type 1 and type 2 diabetes mellitus in Bulgaria

BACKGROUND: This analysis evaluates the cost-effectiveness of insulin degludec (degludec) versus biosimilar insulin glargine U100 (glargine U100) in patients with type 1 (T1DM) and type 2 diabetes mellitus (T2DM) in Bulgaria. METHODS: A simple, short-term model was used to compare the treatment cost...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Endocr Disord
Egile Nagusiak: Russel-Szymczyk, Monika, Valov, Vasil, Savova, Alexandra, Manova, Manoela
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2019
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6891960/
https://ncbi.nlm.nih.gov/pubmed/31796048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-019-0460-6
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak